| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Acrivon Therapeutics, Inc. (ACRV) has 7 insiders with recent SEC Form 4 filings, including 1 buy and 0 sells. ACRV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.10M | $3.52M | - | |
| Other | 225.0K | $378.0K | - | |
| COO | 75.3K | $126.5K | - | |
| Other | 33.1K | $55.6K | - | |
| CFO | 21.0K | $35.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2022 | Ra Capital Management, L.P.53 | Director, 10% Owner | Buy | 3,389,500 | $12.50 | $42,368,750.00 | +340.8% | +43.1% | -75.3% |